Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keane

Showing results (741-750 of 766) with videos related to

Pageof 77
Sort By:
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
Cell Genomics|December 2, 2025
High-quality mouse reference genomes reveal the structural complexity of the murine protein-coding landscapeMohab Helmy, Jin U Li, Xinyu F Yan, et al.
Archives of General Psychiatry|December 8, 2004
Challenges in operationalizing the DSM-IV clinical significance criterionJanette Beals, Douglas K Novins, Paul Spicer, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Nature Reviews. Genetics|September 15, 2019
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022Gary Saunders, Michael Baudis, Regina Becker, et al.
Nature Reviews. Genetics|August 29, 2019
Leveraging European infrastructures to access 1 million human genomes by 2022Gary Saunders, Michael Baudis, Regina Becker, et al.
Contemporary Clinical Trials|July 29, 2018
Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trialAlan L Peterson, Edna B Foa, Tabatha H Blount, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2022
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 77

Showing results (741-750 of 766) with videos related to

Sort By:
Pageof 77
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
Cell Genomics|December 2, 2025
High-quality mouse reference genomes reveal the structural complexity of the murine protein-coding landscapeMohab Helmy, Jin U Li, Xinyu F Yan, et al.
Archives of General Psychiatry|December 8, 2004
Challenges in operationalizing the DSM-IV clinical significance criterionJanette Beals, Douglas K Novins, Paul Spicer, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Nature Reviews. Genetics|September 15, 2019
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022Gary Saunders, Michael Baudis, Regina Becker, et al.
Nature Reviews. Genetics|August 29, 2019
Leveraging European infrastructures to access 1 million human genomes by 2022Gary Saunders, Michael Baudis, Regina Becker, et al.
Contemporary Clinical Trials|July 29, 2018
Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trialAlan L Peterson, Edna B Foa, Tabatha H Blount, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 20, 2022
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trialChadi G Abdallah, John D Roache, Ralitza Gueorguieva, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 77